Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia (Q34116800)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia |
scientific article |
Statements
1 reference
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia (English)
1 reference
Emmanuel Pinard
1 reference
Alexander Alanine
1 reference
Daniela Alberati
1 reference
Markus Bender
1 reference
Edilio Borroni
1 reference
Patrick Bourdeaux
1 reference
Virginie Brom
1 reference
Serge Burner
1 reference
Holger Fischer
1 reference
Dominik Hainzl
1 reference
Remy Halm
1 reference
Nicole Hauser
1 reference
Synese Jolidon
1 reference
Judith Lengyel
1 reference
Hans-Peter Marty
1 reference
Thierry Meyer
1 reference
Jean-Luc Moreau
1 reference
Roland Mory
1 reference
Robert Narquizian
1 reference
Mathias Nettekoven
1 reference
Roger D Norcross
1 reference
Bernd Puellmann
1 reference
Philipp Schmid
1 reference
Sebastien Schmitt
1 reference
Henri Stalder
1 reference
Roger Wermuth
1 reference
Joseph G Wettstein
1 reference
Daniel Zimmerli
1 reference
1 reference
Identifiers
1 reference